TTFields and Adaptive Ultra-Fractionated Radiotherapy for Tumor Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional radiotherapy treatments are rigid and lack personalization, often leading to over or under-treatment due to inflexible fractionation schedules and inadequate adaptation to tumor changes during therapy, while tumor treating fields (TTFields) have shown promise in enhancing radiosensitization but require innovative combinations for optimal efficacy.
Innovation Solution
Combining TTFields with Personalized Ultra-fractionated Adaptive Radiotherapy (PULSAR), which involves applying TTFields at specific frequencies and intervals, along with DNA-damaging agents and immune checkpoint inhibitors, to create conditional vulnerabilities and enhance tumor response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional fractionated radiotherapy is used, then radiation doses can be delivered over time to control malignant cells, but the treatment is rigid and lacks personalization leading to over or under-treatment
Solution Approach 1:
The treatment protocol transitions from static conventional fractionation to dynamic ultra-fractionation with variable intervals (ranging from same-day to multi-week gaps) that can be adjusted based on tumor response, normal tissue recovery, and patient-specific factors. This allows the treatment schedule to adapt in real-time rather than following a rigid predetermined sequence
Solution Approach 2:
The invention changes the temporal parameter of radiation delivery by introducing extended intervals between fractions (ultra-fractionation), moving from traditional daily or near-daily delivery to schedules with gaps ranging from same-day to multi-week intervals. This parameter change enables better tissue recovery while maintaining tumor control
2Object-affected harmful factors
If split-course radiotherapy is used to reduce toxicity, then normal tissue can heal, but tumor control penalties occur due to tumor proliferation during rest periods
Solution Approach 1:
The treatment employs periodic ultra-fractionated doses separated by strategically timed intervals that allow normal tissue recovery while minimizing tumor repopulation. The periodic schedule includes variable gaps (same-day to multi-week) that are optimized based on tissue-specific recovery rates and tumor biology, creating a rhythm of treatment that favors therapeutic ratio
Solution Approach 2:
Low-dose radiation fractions are administered in advance of higher doses, priming the tumor and surrounding tissues. This preliminary action activates DNA damage responses and allows assessment of early treatment response, enabling subsequent dose adjustments before committing to full treatment intensity
3Productivity
If conventional fractionation schedules are used, then treatment can be delivered over a short time frame, but there is little time for tumor or environment changes that might influence adaptation
Solution Approach 1:
The treatment protocol transitions from static conventional fractionation to dynamic ultra-fractionation with variable intervals (ranging from same-day to multi-week gaps) that can be adjusted based on tumor response, normal tissue recovery, and patient-specific factors. This allows the treatment schedule to adapt in real-time rather than following a rigid predetermined sequence
Solution Approach 2:
The extended treatment timeline enables continuous monitoring of tumor response (via imaging, biomarkers, or clinical assessment) and normal tissue tolerance, with subsequent radiation doses and intervals adjusted based on this feedback. This creates a closed-loop system where treatment is modified in real-time based on observed outcomes
4Reliability
If TTFields are applied with conventional radiotherapy, then radiosensitization may be enhanced, but the combination requires innovative approaches for optimal efficacy
Solution Approach 1:
The invention merges TTFields application with ultra-fractionated radiotherapy in a coordinated manner, where both modalities are delivered during the same treatment intervals. The TTFields device electrodes are positioned to cover the radiation field, and both treatments are timed to maximize synergistic effect while sharing the same treatment infrastructure
Solution Approach 2:
The extended intervals between ultra-fractionated doses serve as an intermediary timeframe that allows TTFields to act on tumor cells between radiation exposures. This intermediary period enables the electric fields to induce membrane potential changes and disrupt cell division, creating conditional vulnerabilities that enhance subsequent radiation efficacy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach synergistically increases tumor cell killing by disrupting DNA damage response and replication stress, allowing for adaptive and personalized treatment strategies that improve treatment efficacy and minimize normal tissue toxicity.
Implementation Method 1
TTFields are low intensity alternating electric fields within the intermediate frequency range... applying AC voltages between the transducers... AC voltage is applied between the first pair of transducers for a first interval of time to generate an electric field
Data Source
AI summary
A method of treating a tumor in a subject, the method comprises applying a tumor treating field to the tumor at a frequency between approximately 50 kHz and approximately 1,000 kHz; and delivering personalized ultra-fractionated adaptive radiotherapy (PULSAR) regimen.